Bioequivalence clinical trial of two formulations of linagliptin/metformin.
This study is a bioequivalence clinical trial, which means researchers are comparing two different versions of the same medicine. The medicine in question contains linagliptin and metformin, which are used to help control blood sugar levels. However, this study is recruiting healthy volunteers, not people with diabetes. The main goal is to check if the body absorbs and uses both versions of the medicine in the same way. This is an important step in developing new medicines, as it helps ensure that a new version of a drug will work just as effectively and safely as an existing one. It's a phase I study, meaning it's one of the first human trials, focusing on how the medicine behaves in the body.
At a glance
What is this study about?
You might be wondering what a 'bioequivalence clinical trial' means. Simply put, it's a type of study where scientists compare two versions of the same medicine to see if they both act the same way in the body. Imagine you have two different brands of a painkiller; this study wants to know if your body uses the active ingredient from both brands in the same way, at the same speed, and to the same extent. This particular study is looking at two versions of a medicine that contains linagliptin and metformin, which are drugs typically used to help manage blood sugar levels in people with diabetes.
The important thing to note is that this study is for healthy volunteers. This means they are not recruiting people who have diabetes or any other major health conditions. The reason for this is to remove other health factors that might make it harder to see how the medicine itself is behaving in the body without other influences. By studying healthy people, researchers can get a clear picture of how the medicine is absorbed, processed, and removed by the body.
This kind of research is really important for ensuring that new medicines, or new versions of existing medicines, are safe and effective when they eventually become available to patients. It’s part of the careful testing process all medicines go through. By taking part, healthy volunteers play a crucial role in helping to bring trusted medications to those who need them.
Key takeaways
- Researchers are comparing two versions of a blood sugar medicine in healthy people.
- This study helps ensure new medicines work just like existing ones.
- It's open to healthy adults, both men and women, aged 18 and over.
- Participation involves clinic visits and blood tests to monitor the medicine.
- Taking part helps advance medical knowledge.
- You can stop participating at any time.
Who may be eligible?
To join this study, you need to be a healthy adult who is at least 18 years old. There's no upper age limit, meaning older adults are welcome to participate if they meet the other health criteria.
Both men and women can take part in this research. The study isn't focused on specific genders, as it's looking at how the medicine works in the body generally.
Because this is a study for healthy volunteers, you must not have any significant ongoing medical conditions. The research team will do a health check to make sure you're suitable and in good health before you can join.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you generally in good health?
- Do you not have any major ongoing medical conditions (like diabetes)?
- Are you available for multiple clinic visits over a set period?
What does participation involve?
If you decide to take part, you'll be given two different versions of the linagliptin/metformin medicine to compare. The study will involve several visits to a clinic over a period of time. During these visits, the research team will take blood samples frequently to measure how the medicine is behaving in your body. You might also have other health checks like blood pressure and heart rate measurements. You will be carefully monitored by medical staff throughout the study. After the dosing periods, there will be a follow-up to ensure you are well. The total duration of your involvement, including all visits and follow-ups, will be explained in detail before you agree to participate.
Potential risks and benefits
Locations (1)
- —UnverifiedSpain
Common questions
What is 'bioequivalence'?
Bioequivalence means that two different versions of the same medicine are absorbed by the body in the same way and act in the body in the same way.
Why are healthy volunteers needed?
Healthy volunteers help researchers understand how a new medicine works in the body without other health conditions affecting the results.
Will I be given a real medicine?
Yes, you will be given versions of linagliptin/metformin, which is a real medicine, but you don't have diabetes so it won't be used to treat a condition.
How long will the study take?
The full details of the study duration, including clinic visits and follow-ups, will be given to you by the research team.
Do I have to take part?
No, taking part is completely voluntary. You can decide not to join, or withdraw at any time, without it affecting your usual healthcare.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.